nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0857	0.137	CbGbCtD
Hydroxyurea—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0806	0.129	CbGbCtD
Hydroxyurea—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0806	0.129	CbGbCtD
Hydroxyurea—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0729	0.116	CbGbCtD
Hydroxyurea—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0729	0.116	CbGbCtD
Hydroxyurea—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0629	0.1	CbGbCtD
Hydroxyurea—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0611	0.0974	CbGbCtD
Hydroxyurea—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0552	0.0881	CbGbCtD
Hydroxyurea—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0552	0.0881	CbGbCtD
Hydroxyurea—RRM2—skin of body—acquired immunodeficiency syndrome	0.00425	0.0594	CbGeAlD
Hydroxyurea—RRM1—retina—acquired immunodeficiency syndrome	0.00402	0.0562	CbGeAlD
Hydroxyurea—RRM1—skin of body—acquired immunodeficiency syndrome	0.00353	0.0494	CbGeAlD
Hydroxyurea—RRM2—lymphoid tissue—acquired immunodeficiency syndrome	0.00344	0.0481	CbGeAlD
Hydroxyurea—RRM2—digestive system—acquired immunodeficiency syndrome	0.0034	0.0475	CbGeAlD
Hydroxyurea—RRM2—blood—acquired immunodeficiency syndrome	0.00324	0.0453	CbGeAlD
Hydroxyurea—RRM2—bone marrow—acquired immunodeficiency syndrome	0.00313	0.0438	CbGeAlD
Hydroxyurea—RRM2—vagina—acquired immunodeficiency syndrome	0.003	0.042	CbGeAlD
Hydroxyurea—RRM1—lymphoid tissue—acquired immunodeficiency syndrome	0.00286	0.04	CbGeAlD
Hydroxyurea—RRM2—lung—acquired immunodeficiency syndrome	0.00284	0.0397	CbGeAlD
Hydroxyurea—RRM1—digestive system—acquired immunodeficiency syndrome	0.00282	0.0395	CbGeAlD
Hydroxyurea—RRM1—blood—acquired immunodeficiency syndrome	0.00269	0.0376	CbGeAlD
Hydroxyurea—RRM2—nervous system—acquired immunodeficiency syndrome	0.00263	0.0367	CbGeAlD
Hydroxyurea—RRM1—bone marrow—acquired immunodeficiency syndrome	0.0026	0.0364	CbGeAlD
Hydroxyurea—RRM1—spinal cord—acquired immunodeficiency syndrome	0.00259	0.0362	CbGeAlD
Hydroxyurea—RRM2—central nervous system—acquired immunodeficiency syndrome	0.00253	0.0354	CbGeAlD
Hydroxyurea—RRM1—vagina—acquired immunodeficiency syndrome	0.00249	0.0349	CbGeAlD
Hydroxyurea—RRM1—lung—acquired immunodeficiency syndrome	0.00236	0.033	CbGeAlD
Hydroxyurea—RRM1—nervous system—acquired immunodeficiency syndrome	0.00218	0.0305	CbGeAlD
Hydroxyurea—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00218	0.0305	CbGeAlD
Hydroxyurea—RRM1—central nervous system—acquired immunodeficiency syndrome	0.0021	0.0294	CbGeAlD
Hydroxyurea—RRM2—brain—acquired immunodeficiency syndrome	0.00201	0.0281	CbGeAlD
Hydroxyurea—RRM2—lymph node—acquired immunodeficiency syndrome	0.00194	0.0271	CbGeAlD
Hydroxyurea—RRM1—brain—acquired immunodeficiency syndrome	0.00167	0.0233	CbGeAlD
Hydroxyurea—RRM1—lymph node—acquired immunodeficiency syndrome	0.00161	0.0225	CbGeAlD
Hydroxyurea—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000839	0.0117	CbGeAlD
Hydroxyurea—CYP2D6—blood—acquired immunodeficiency syndrome	0.000799	0.0112	CbGeAlD
Hydroxyurea—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000649	0.00907	CbGeAlD
Hydroxyurea—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000624	0.00873	CbGeAlD
Hydroxyurea—CYP2D6—brain—acquired immunodeficiency syndrome	0.000496	0.00693	CbGeAlD
Hydroxyurea—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000347	0.00115	CcSEcCtD
Hydroxyurea—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000347	0.00115	CcSEcCtD
Hydroxyurea—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000346	0.00115	CcSEcCtD
Hydroxyurea—Chills—Saquinavir—acquired immunodeficiency syndrome	0.000344	0.00114	CcSEcCtD
Hydroxyurea—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000343	0.00114	CcSEcCtD
Hydroxyurea—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.00034	0.00113	CcSEcCtD
Hydroxyurea—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00034	0.00113	CcSEcCtD
Hydroxyurea—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000339	0.00112	CcSEcCtD
Hydroxyurea—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000339	0.00112	CcSEcCtD
Hydroxyurea—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.000338	0.00112	CcSEcCtD
Hydroxyurea—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000337	0.00112	CcSEcCtD
Hydroxyurea—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000336	0.00111	CcSEcCtD
Hydroxyurea—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.000334	0.00111	CcSEcCtD
Hydroxyurea—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000334	0.00111	CcSEcCtD
Hydroxyurea—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000334	0.00111	CcSEcCtD
Hydroxyurea—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000332	0.0011	CcSEcCtD
Hydroxyurea—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000332	0.0011	CcSEcCtD
Hydroxyurea—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000332	0.0011	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000332	0.0011	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000332	0.0011	CcSEcCtD
Hydroxyurea—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000331	0.0011	CcSEcCtD
Hydroxyurea—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00033	0.0011	CcSEcCtD
Hydroxyurea—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00033	0.00109	CcSEcCtD
Hydroxyurea—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000329	0.00109	CcSEcCtD
Hydroxyurea—Chills—Lamivudine—acquired immunodeficiency syndrome	0.000329	0.00109	CcSEcCtD
Hydroxyurea—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000326	0.00108	CcSEcCtD
Hydroxyurea—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000325	0.00108	CcSEcCtD
Hydroxyurea—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000324	0.00107	CcSEcCtD
Hydroxyurea—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000324	0.00107	CcSEcCtD
Hydroxyurea—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000323	0.00107	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000322	0.00107	CcSEcCtD
Hydroxyurea—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000321	0.00106	CcSEcCtD
Hydroxyurea—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000321	0.00106	CcSEcCtD
Hydroxyurea—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00032	0.00106	CcSEcCtD
Hydroxyurea—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000319	0.00106	CcSEcCtD
Hydroxyurea—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000317	0.00105	CcSEcCtD
Hydroxyurea—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000316	0.00105	CcSEcCtD
Hydroxyurea—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000315	0.00104	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000315	0.00104	CcSEcCtD
Hydroxyurea—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000314	0.00104	CcSEcCtD
Hydroxyurea—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000314	0.00104	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000313	0.00104	CcSEcCtD
Hydroxyurea—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000313	0.00104	CcSEcCtD
Hydroxyurea—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000312	0.00103	CcSEcCtD
Hydroxyurea—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000312	0.00103	CcSEcCtD
Hydroxyurea—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000312	0.00103	CcSEcCtD
Hydroxyurea—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000311	0.00103	CcSEcCtD
Hydroxyurea—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000311	0.00103	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.00031	0.00103	CcSEcCtD
Hydroxyurea—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00031	0.00103	CcSEcCtD
Hydroxyurea—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000309	0.00102	CcSEcCtD
Hydroxyurea—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000309	0.00102	CcSEcCtD
Hydroxyurea—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000307	0.00102	CcSEcCtD
Hydroxyurea—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000306	0.00102	CcSEcCtD
Hydroxyurea—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000305	0.00101	CcSEcCtD
Hydroxyurea—Rash—Didanosine—acquired immunodeficiency syndrome	0.000304	0.00101	CcSEcCtD
Hydroxyurea—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000304	0.00101	CcSEcCtD
Hydroxyurea—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000304	0.00101	CcSEcCtD
Hydroxyurea—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000304	0.00101	CcSEcCtD
Hydroxyurea—Headache—Didanosine—acquired immunodeficiency syndrome	0.000303	0.001	CcSEcCtD
Hydroxyurea—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000302	0.001	CcSEcCtD
Hydroxyurea—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000302	0.001	CcSEcCtD
Hydroxyurea—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000301	0.000999	CcSEcCtD
Hydroxyurea—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000301	0.000999	CcSEcCtD
Hydroxyurea—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000301	0.000998	CcSEcCtD
Hydroxyurea—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000301	0.000998	CcSEcCtD
Hydroxyurea—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.0003	0.000996	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.0003	0.000995	CcSEcCtD
Hydroxyurea—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000299	0.000992	CcSEcCtD
Hydroxyurea—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000298	0.000989	CcSEcCtD
Hydroxyurea—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000298	0.000987	CcSEcCtD
Hydroxyurea—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000297	0.000985	CcSEcCtD
Hydroxyurea—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000296	0.000983	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000296	0.000981	CcSEcCtD
Hydroxyurea—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000295	0.000977	CcSEcCtD
Hydroxyurea—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000295	0.000977	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000293	0.000973	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000293	0.00097	CcSEcCtD
Hydroxyurea—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000292	0.000969	CcSEcCtD
Hydroxyurea—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.000969	CcSEcCtD
Hydroxyurea—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000292	0.000969	CcSEcCtD
Hydroxyurea—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00029	0.000961	CcSEcCtD
Hydroxyurea—Pain—Indinavir—acquired immunodeficiency syndrome	0.00029	0.000961	CcSEcCtD
Hydroxyurea—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000289	0.00096	CcSEcCtD
Hydroxyurea—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000288	0.000955	CcSEcCtD
Hydroxyurea—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000288	0.000954	CcSEcCtD
Hydroxyurea—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000287	0.000953	CcSEcCtD
Hydroxyurea—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000287	0.000951	CcSEcCtD
Hydroxyurea—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000287	0.000951	CcSEcCtD
Hydroxyurea—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000285	0.000947	CcSEcCtD
Hydroxyurea—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000285	0.000946	CcSEcCtD
Hydroxyurea—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000285	0.000944	CcSEcCtD
Hydroxyurea—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000283	0.00094	CcSEcCtD
Hydroxyurea—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000283	0.000937	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000282	0.000937	CcSEcCtD
Hydroxyurea—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000282	0.000935	CcSEcCtD
Hydroxyurea—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000281	0.000932	CcSEcCtD
Hydroxyurea—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000279	0.000926	CcSEcCtD
Hydroxyurea—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000278	0.000923	CcSEcCtD
Hydroxyurea—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000278	0.000922	CcSEcCtD
Hydroxyurea—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000278	0.000922	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000277	0.00092	CcSEcCtD
Hydroxyurea—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000277	0.00092	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000276	0.000917	CcSEcCtD
Hydroxyurea—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000276	0.000916	CcSEcCtD
Hydroxyurea—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000276	0.000916	CcSEcCtD
Hydroxyurea—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000276	0.000916	CcSEcCtD
Hydroxyurea—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000275	0.000913	CcSEcCtD
Hydroxyurea—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000274	0.000908	CcSEcCtD
Hydroxyurea—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000274	0.000908	CcSEcCtD
Hydroxyurea—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000274	0.000908	CcSEcCtD
Hydroxyurea—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000274	0.000907	CcSEcCtD
Hydroxyurea—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000273	0.000906	CcSEcCtD
Hydroxyurea—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000273	0.000906	CcSEcCtD
Hydroxyurea—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000273	0.000904	CcSEcCtD
Hydroxyurea—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000272	0.000903	CcSEcCtD
Hydroxyurea—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000272	0.000902	CcSEcCtD
Hydroxyurea—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000271	0.000899	CcSEcCtD
Hydroxyurea—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.000896	CcSEcCtD
Hydroxyurea—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00027	0.000894	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.000894	CcSEcCtD
Hydroxyurea—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000268	0.000889	CcSEcCtD
Hydroxyurea—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000268	0.000889	CcSEcCtD
Hydroxyurea—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000267	0.000887	CcSEcCtD
Hydroxyurea—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000267	0.000887	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000267	0.000886	CcSEcCtD
Hydroxyurea—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000267	0.000884	CcSEcCtD
Hydroxyurea—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000266	0.000883	CcSEcCtD
Hydroxyurea—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000265	0.00088	CcSEcCtD
Hydroxyurea—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000265	0.000879	CcSEcCtD
Hydroxyurea—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000265	0.000879	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000264	0.000877	CcSEcCtD
Hydroxyurea—Rash—Stavudine—acquired immunodeficiency syndrome	0.000264	0.000877	CcSEcCtD
Hydroxyurea—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000264	0.000876	CcSEcCtD
Hydroxyurea—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000264	0.000876	CcSEcCtD
Hydroxyurea—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000264	0.000875	CcSEcCtD
Hydroxyurea—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000263	0.000874	CcSEcCtD
Hydroxyurea—Headache—Stavudine—acquired immunodeficiency syndrome	0.000263	0.000871	CcSEcCtD
Hydroxyurea—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000263	0.000871	CcSEcCtD
Hydroxyurea—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.000869	CcSEcCtD
Hydroxyurea—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.000869	CcSEcCtD
Hydroxyurea—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000261	0.000867	CcSEcCtD
Hydroxyurea—Rash—Abacavir—acquired immunodeficiency syndrome	0.00026	0.000864	CcSEcCtD
Hydroxyurea—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00026	0.000863	CcSEcCtD
Hydroxyurea—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00026	0.000863	CcSEcCtD
Hydroxyurea—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.000862	CcSEcCtD
Hydroxyurea—Headache—Abacavir—acquired immunodeficiency syndrome	0.000259	0.000858	CcSEcCtD
Hydroxyurea—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.000857	CcSEcCtD
Hydroxyurea—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000258	0.000856	CcSEcCtD
Hydroxyurea—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000255	0.000846	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000255	0.000845	CcSEcCtD
Hydroxyurea—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000253	0.00084	CcSEcCtD
Hydroxyurea—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000253	0.000838	CcSEcCtD
Hydroxyurea—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000253	0.000838	CcSEcCtD
Hydroxyurea—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000252	0.000837	CcSEcCtD
Hydroxyurea—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.000835	CcSEcCtD
Hydroxyurea—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00025	0.000829	CcSEcCtD
Hydroxyurea—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00025	0.000828	CcSEcCtD
Hydroxyurea—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000249	0.000827	CcSEcCtD
Hydroxyurea—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000249	0.000827	CcSEcCtD
Hydroxyurea—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000249	0.000826	CcSEcCtD
Hydroxyurea—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.000822	CcSEcCtD
Hydroxyurea—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000246	0.000817	CcSEcCtD
Hydroxyurea—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000245	0.000814	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000245	0.000811	CcSEcCtD
Hydroxyurea—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000244	0.00081	CcSEcCtD
Hydroxyurea—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000243	0.000806	CcSEcCtD
Hydroxyurea—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.000806	CcSEcCtD
Hydroxyurea—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000242	0.000804	CcSEcCtD
Hydroxyurea—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.000804	CcSEcCtD
Hydroxyurea—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.000804	CcSEcCtD
Hydroxyurea—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000242	0.000803	CcSEcCtD
Hydroxyurea—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000241	0.000799	CcSEcCtD
Hydroxyurea—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.000796	CcSEcCtD
Hydroxyurea—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.000786	CcSEcCtD
Hydroxyurea—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000236	0.000782	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000235	0.000781	CcSEcCtD
Hydroxyurea—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000235	0.00078	CcSEcCtD
Hydroxyurea—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.000774	CcSEcCtD
Hydroxyurea—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.000773	CcSEcCtD
Hydroxyurea—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.000773	CcSEcCtD
Hydroxyurea—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.000769	CcSEcCtD
Hydroxyurea—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000232	0.000769	CcSEcCtD
Hydroxyurea—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000232	0.000768	CcSEcCtD
Hydroxyurea—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.000767	CcSEcCtD
Hydroxyurea—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00023	0.000762	CcSEcCtD
Hydroxyurea—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00023	0.000762	CcSEcCtD
Hydroxyurea—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00023	0.000761	CcSEcCtD
Hydroxyurea—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.00076	CcSEcCtD
Hydroxyurea—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000228	0.000757	CcSEcCtD
Hydroxyurea—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.00075	CcSEcCtD
Hydroxyurea—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.000749	CcSEcCtD
Hydroxyurea—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.000745	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000225	0.000745	CcSEcCtD
Hydroxyurea—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000224	0.000744	CcSEcCtD
Hydroxyurea—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000224	0.000743	CcSEcCtD
Hydroxyurea—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.000743	CcSEcCtD
Hydroxyurea—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.000738	CcSEcCtD
Hydroxyurea—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.000738	CcSEcCtD
Hydroxyurea—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.000729	CcSEcCtD
Hydroxyurea—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000219	0.000727	CcSEcCtD
Hydroxyurea—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000216	0.000718	CcSEcCtD
Hydroxyurea—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.000715	CcSEcCtD
Hydroxyurea—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000215	0.000715	CcSEcCtD
Hydroxyurea—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.000711	CcSEcCtD
Hydroxyurea—Rash—Indinavir—acquired immunodeficiency syndrome	0.000214	0.000709	CcSEcCtD
Hydroxyurea—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000213	0.000708	CcSEcCtD
Hydroxyurea—Headache—Indinavir—acquired immunodeficiency syndrome	0.000212	0.000704	CcSEcCtD
Hydroxyurea—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000212	0.000702	CcSEcCtD
Hydroxyurea—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00021	0.000695	CcSEcCtD
Hydroxyurea—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.000692	CcSEcCtD
Hydroxyurea—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.000682	CcSEcCtD
Hydroxyurea—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.000675	CcSEcCtD
Hydroxyurea—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.000674	CcSEcCtD
Hydroxyurea—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.000672	CcSEcCtD
Hydroxyurea—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.00067	CcSEcCtD
Hydroxyurea—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.000669	CcSEcCtD
Hydroxyurea—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000201	0.000668	CcSEcCtD
Hydroxyurea—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.000666	CcSEcCtD
Hydroxyurea—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000201	0.000665	CcSEcCtD
Hydroxyurea—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000649	CcSEcCtD
Hydroxyurea—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.000646	CcSEcCtD
Hydroxyurea—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.000643	CcSEcCtD
Hydroxyurea—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.000641	CcSEcCtD
Hydroxyurea—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.00064	CcSEcCtD
Hydroxyurea—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.000637	CcSEcCtD
Hydroxyurea—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000636	CcSEcCtD
Hydroxyurea—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00019	0.000631	CcSEcCtD
Hydroxyurea—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.000621	CcSEcCtD
Hydroxyurea—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000619	CcSEcCtD
Hydroxyurea—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000619	CcSEcCtD
Hydroxyurea—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.000604	CcSEcCtD
Hydroxyurea—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.000598	CcSEcCtD
Hydroxyurea—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.000597	CcSEcCtD
Hydroxyurea—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000592	CcSEcCtD
Hydroxyurea—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000592	CcSEcCtD
Hydroxyurea—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.00059	CcSEcCtD
Hydroxyurea—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000589	CcSEcCtD
Hydroxyurea—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000173	0.000575	CcSEcCtD
Hydroxyurea—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000571	CcSEcCtD
Hydroxyurea—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.00057	CcSEcCtD
Hydroxyurea—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.00057	CcSEcCtD
Hydroxyurea—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000567	CcSEcCtD
Hydroxyurea—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.000558	CcSEcCtD
Hydroxyurea—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.000549	CcSEcCtD
Hydroxyurea—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000544	CcSEcCtD
Hydroxyurea—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000544	CcSEcCtD
Hydroxyurea—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000541	CcSEcCtD
Hydroxyurea—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.000537	CcSEcCtD
Hydroxyurea—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000513	CcSEcCtD
